Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cardinali

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Neuro-Signals|January 24, 2004
Circadian disorganization in experimental arthritisDaniel P Cardinali, Ana I Esquifino
Frontiers in Pharmacology|May 3, 2021
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's DiseaseSantiago Pérez-Lloret, Daniel P Cardinali
Cellular and Molecular Life Sciences : CMLS|August 19, 2017
Melatonin, mitochondria, and the metabolic syndromeDaniel P Cardinali, Daniel E Vigo
Neuro Endocrinology Letters|July 20, 2001
Effects of melatonin on 24-h rhythms of neuroendocrine and immune changes in Freund's adjuvant-induced arthritisAna I. Esquifino, Daniel P. Cardinali
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 18, 2024
Clinical use of melatonin in osteoporosis: Expectations still unmetDaniel P Cardinali, Russel J Reiter
Lancet (London, England)|December 5, 2008
Let there be sleep--on timeDaniel P Cardinali, Diego A Golombek
Medicina|November 8, 2011
Melatonin in Chagas' disease. Possible therapeutic valueDaniel P Cardinali, Carlos B Alvarez
Npj Biological Timing and Sleep|March 3, 2026
Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matterDaniel P Cardinali, Daniel E Vigo
Neuro Endocrinology Letters|July 17, 2001
Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's diseaseLuis I. Brusco, Miguel Márquez, Daniel P. Cardinali
Neuroendocrinology|December 23, 2016
PrefaceEduardo Spinedi, Daniel P Cardinali, Juan J Gagliardino
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Neuro-Signals|January 24, 2004
Circadian disorganization in experimental arthritisDaniel P Cardinali, Ana I Esquifino
Frontiers in Pharmacology|May 3, 2021
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's DiseaseSantiago Pérez-Lloret, Daniel P Cardinali
Cellular and Molecular Life Sciences : CMLS|August 19, 2017
Melatonin, mitochondria, and the metabolic syndromeDaniel P Cardinali, Daniel E Vigo
Neuro Endocrinology Letters|July 20, 2001
Effects of melatonin on 24-h rhythms of neuroendocrine and immune changes in Freund's adjuvant-induced arthritisAna I. Esquifino, Daniel P. Cardinali
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 18, 2024
Clinical use of melatonin in osteoporosis: Expectations still unmetDaniel P Cardinali, Russel J Reiter
Lancet (London, England)|December 5, 2008
Let there be sleep--on timeDaniel P Cardinali, Diego A Golombek
Medicina|November 8, 2011
Melatonin in Chagas' disease. Possible therapeutic valueDaniel P Cardinali, Carlos B Alvarez
Npj Biological Timing and Sleep|March 3, 2026
Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matterDaniel P Cardinali, Daniel E Vigo
Neuro Endocrinology Letters|July 17, 2001
Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's diseaseLuis I. Brusco, Miguel Márquez, Daniel P. Cardinali
Neuroendocrinology|December 23, 2016
PrefaceEduardo Spinedi, Daniel P Cardinali, Juan J Gagliardino
Pageof 20